STAT3 and non-small cell lung carcinoma: We therefore investigated the relevance of STAT3 to the sensitization of lung cancer cells to paclitaxel treatment, by assessing the correlation between paclitaxel response, protein levels of total STAT3 and phospho-STAT3 (pSTAT3) and levels of miR-337-3p in a panel of NSCLC cell lines.